297 related articles for article (PubMed ID: 28077249)
1. Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease.
Béres NJ; Kiss Z; Sztupinszki Z; Lendvai G; Arató A; Sziksz E; Vannay Á; Szabó AJ; Müller KE; Cseh Á; Boros K; Veres G
Dig Liver Dis; 2017 Apr; 49(4):378-387. PubMed ID: 28077249
[TBL] [Abstract][Full Text] [Related]
2. Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.
Béres NJ; Szabó D; Kocsis D; Szűcs D; Kiss Z; Müller KE; Lendvai G; Kiss A; Arató A; Sziksz E; Vannay Á; Szabó AJ; Veres G
Inflamm Bowel Dis; 2016 Feb; 22(2):327-35. PubMed ID: 26752469
[TBL] [Abstract][Full Text] [Related]
3. Increased duodenal expression of miR-146a and -155 in pediatric Crohn's disease.
Szűcs D; Béres NJ; Rokonay R; Boros K; Borka K; Kiss Z; Arató A; Szabó AJ; Vannay Á; Sziksz E; Bereczki C; Veres G
World J Gastroenterol; 2016 Jul; 22(26):6027-35. PubMed ID: 27468194
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
5. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease.
Fasseu M; Tréton X; Guichard C; Pedruzzi E; Cazals-Hatem D; Richard C; Aparicio T; Daniel F; Soulé JC; Moreau R; Bouhnik Y; Laburthe M; Groyer A; Ogier-Denis E
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957151
[TBL] [Abstract][Full Text] [Related]
6. Elevated miRNA Inversely Correlates with
Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K
Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases - hallmark of epithelial-mesenchymal transition.
Zidar N; Boštjančič E; Jerala M; Kojc N; Drobne D; Štabuc B; Glavač D
J Cell Mol Med; 2016 Oct; 20(10):1813-20. PubMed ID: 27113480
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients.
Valmiki S; Ahuja V; Paul J
World J Gastroenterol; 2017 Aug; 23(29):5324-5332. PubMed ID: 28839432
[TBL] [Abstract][Full Text] [Related]
9. Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon.
Zahm AM; Hand NJ; Tsoucas DM; Le Guen CL; Baldassano RN; Friedman JR
J Crohns Colitis; 2014 Sep; 8(9):1108-17. PubMed ID: 24613022
[TBL] [Abstract][Full Text] [Related]
10. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.
Koukos G; Polytarchou C; Kaplan JL; Morley-Fletcher A; Gras-Miralles B; Kokkotou E; Baril-Dore M; Pothoulakis C; Winter HS; Iliopoulos D
Gastroenterology; 2013 Oct; 145(4):842-52.e2. PubMed ID: 23856509
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA in inflammatory bowel disease: Translational research and clinical implication.
Fisher K; Lin J
World J Gastroenterol; 2015 Nov; 21(43):12274-82. PubMed ID: 26604636
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases.
Ge Y; Sun M; Wu W; Ma C; Zhang C; He C; Li J; Cong Y; Zhang D; Liu Z
J Autoimmun; 2019 Jul; 101():109-120. PubMed ID: 31014918
[TBL] [Abstract][Full Text] [Related]
14. Gene expression alterations in inflamed and unaffected colon mucosa from patients with mild inflammatory bowel disease.
Xu L; Ma L; Lian J; Yang J; Chen S
Mol Med Rep; 2016 Mar; 13(3):2729-35. PubMed ID: 26861951
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of MicroRNA-21 in Colonic CD3+ T Cells in UC Remission.
Ando Y; Mazzurana L; Forkel M; Okazaki K; Aoi M; Schmidt PT; Mjösberg J; Bresso F
Inflamm Bowel Dis; 2016 Dec; 22(12):2788-2793. PubMed ID: 27824649
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis.
Dubois-Camacho K; Diaz-Jimenez D; De la Fuente M; Quera R; Simian D; Martínez M; Landskron G; Olivares-Morales M; Cidlowski JA; Xu X; Gao G; Xie J; Chnaiderman J; Soto-Rifo R; González MJ; Calixto A; Hermoso MA
Front Immunol; 2019; 10():2449. PubMed ID: 31824476
[TBL] [Abstract][Full Text] [Related]
17. Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing.
Lin J; Zhang X; Zhao Z; Welker NC; Li Y; Liu Y; Bronner MP
Microrna; 2016; 5(3):222-229. PubMed ID: 27855604
[TBL] [Abstract][Full Text] [Related]
18. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4
Nie J; Zhao Q
Front Immunol; 2020; 11():852. PubMed ID: 32547537
[No Abstract] [Full Text] [Related]
19. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel disease.
Konstantinidis AΟ; Pardali D; Adamama-Moraitou KK; Gazouli M; Dovas CI; Legaki E; Brellou GD; Savvas I; Jergens AE; Rallis TS; Allenspach K
BMC Vet Res; 2020 Feb; 16(1):69. PubMed ID: 32087719
[TBL] [Abstract][Full Text] [Related]
20. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens.
Velikova T; Kyurkchiev D; Spassova Z; Karakolev I; Ivanova-Todorova E; Altankova I; Stanilova S
Cytokine; 2017 Apr; 92():12-19. PubMed ID: 28088612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
